Assignee

Seattle Genetics, Inc.

Patents = 132

Trademarks = 25

Forward Citations = 4,489

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

202 inventors (with patents filed for the assignee):

Seattle Genetics is a biotechnology company focused on developing innovative antibody-based therapies for the treatment of cancer. The companys proprietary ADC technology platform allows targeted delivery of potent medicines to cancer cells while sparing healthy tissues. Seattle Genetics is dedicated to improving patient outcomes by advancing the field of precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com